, in development with the University of Oxford, may also generate investor concern. The biopharma firm's Phase 3 study has been kept on hold after a participant in the UK was suspected of a serious adverse reaction.
The bill aims to transfer powers previously held by the EU to regulate issues such as food standards and environment policy to the four UK nations - England, Wales, Scotland, and Northern Ireland - and to keep trade free-flowing after Brexit.
हमने इस समाचार को संक्षेप में प्रस्तुत किया है ताकि आप इसे तुरंत पढ़ सकें। यदि आप समाचार में रुचि रखते हैं, तो आप पूरा पाठ यहां पढ़ सकते हैं। और पढो: